Skip to content

Drug interactions

Siponimod + Sorafenib

Severity: Major

Siponimod and Sorafenib: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Sorafenib inhibits CYP2C9 and may raise siponimod exposure, and both drugs can prolong the QT interval. Siponimod also slows heart rate, so arrhythmia risk is increased.

What this interaction means in plain words

Siponimod and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Siponimod belongs to Central Nervous System; Sorafenib belongs to Oncology.

Evidence level: Low

Why it happens

CYP2C9 inhibition by sorafenib reduces siponimod clearance, combined with additive QT prolongation.

What to do

Avoid if an alternative exists. If used together, obtain a baseline ECG, correct potassium and magnesium, and monitor ECG and heart rate.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Siponimod and Sorafenib, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Siponimod with Sorafenib?

MediHelp rates the interaction as major. Siponimod and Sorafenib can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Sorafenib inhibits CYP2C9 and may raise siponimod exposure, and both drugs can prolong the QT interval. Siponimod also slows heart rate, so arrhythmia risk is increased.

How serious is the interaction between Siponimod and Sorafenib?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid if an alternative exists. If used together, obtain a baseline ECG, correct potassium and magnesium, and monitor ECG and heart rate.

What other medicines interact with Siponimod?

MediHelp also lists interactions of Siponimod with, for example, Cladribine, Fingolimod, Fluconazole. The full list is on the Siponimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in